title: Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA)
authors.forename: S H
authors.initials: SH
authors.lastname: Kroft
authors.forename: M S
authors.initials: MS
authors.lastname: Tallman
authors.forename: J M
authors.initials: JM
authors.lastname: Shaw
authors.forename: M
authors.initials: M
authors.lastname: Thangavelu
authors.forename: L C
authors.initials: LC
authors.lastname: Peterson
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002897:Chromosomes, Human, Pair 7; D017338:Cladribine / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009006:Monosomy; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D017338:Cladribine